Serennity007 US Stock Evaluation
⚠️ Data Verification — Do This Before Any Analysis
Before running any analysis, always retrieve the latest market data for the ticker:
- Fetch current price — use web search or ask the user for the live price, 52-week range, and market cap. Never assume a price from training data.
- Confirm key figures — recent earnings, revenue, key ratios (P/E, P/S, etc.) as applicable to this skill.
- State your data source — note where the numbers came from (e.g., "Google Finance, June 19 2026") at the top of the output.
- Flag stale data explicitly — if live data is unavailable, display this warning before proceeding:
⚠️ Live data unavailable. The following analysis uses training-data estimates which may be significantly out of date. Verify all prices and metrics before making any decisions.
Never silently substitute training-data estimates for current prices. When in doubt, ask the user to paste the latest quote.
Perform comprehensive stock evaluation combining fundamental analysis, valuation modeling, quality scoring, and risk assessment to produce investment-grade conclusions.
Analysis Components
1. Company Overview
- Business model and competitive advantages (moat assessment)
- Market position, addressable market size, and industry trends
- Revenue mix by segment and geographic exposure
- Key products, services, and customer concentration
- Competitive dynamics and threat of disruption
2. Financial Health
- Revenue and earnings growth trends (3-year and 5-year CAGR)
- Profit margins: gross margin, operating margin, net margin
- Margin trends: expanding, stable, or compressing
- Balance sheet strength: cash, total debt, net debt, book value
- Liquidity: current ratio, quick ratio, cash conversion cycle
- Cash flow analysis: operating cash flow, free cash flow, FCF yield
- Capital expenditure requirements (maintenance vs. growth capex)
- Working capital management efficiency
3. Valuation Metrics
| Metric | Current | 1-Year Ago | 5-Year Avg | Sector Avg |
|---|---|---|---|---|
| P/E (TTM) | ||||
| P/E (Forward) | ||||
| PEG Ratio | ||||
| Price/Book | ||||
| Price/Sales | ||||
| EV/EBITDA | ||||
| EV/FCF | ||||
| Dividend Yield | ||||
| Payout Ratio |
4. Key Ratios
| Ratio | Current | Industry Avg | Assessment |
|---|---|---|---|
| Return on Equity (ROE) | |||
| Return on Assets (ROA) | |||
| Return on Inv. Capital | |||
| Gross Margin | |||
| Operating Margin | |||
| Net Margin | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity | |||
| Interest Coverage | |||
| Asset Turnover |
5. Peer Comparison
- Direct peer comparison within industry on key valuation multiples
- Historical valuation trends vs. own 5-year history
- Sector performance context and relative positioning
- Market share trends vs. competitors
Deep Financial Statement Analysis
This section provides line-item rigor absorbed from dedicated fundamental analysis workflows. Use when a deeper statement-level breakdown is required.
Income Statement Line-Item Framework
Revenue Analysis
- Break revenue into organic growth vs. acquisition-driven growth vs. FX tailwind/headwind
- Identify top revenue segments by size and growth rate; flag any segment growing faster or slower than the consolidated total
- Assess revenue quality: recurring subscription/contract revenue vs. transactional/one-time revenue
- Operating leverage test: does revenue growth outpace operating expense growth? Calculate incremental operating margin = ΔOperating Income / ΔRevenue
Cost Structure Decomposition
- COGS breakdown: raw materials, labor, overhead — track each as % of revenue over 5 years
- SG&A as % of revenue: stable or creeping? Rising SG&A without revenue acceleration signals inefficiency
- R&D intensity: absolute spend and % of revenue — context-dependent (biotech vs. consumer goods)
- Non-recurring items to strip from normalized earnings: restructuring charges, asset write-downs, gain/loss on asset sales, one-time tax benefits, litigation settlements
Operating Leverage Analysis
- Fixed vs. variable cost split (estimate from historical margin behavior at different revenue levels)
- Degree of Operating Leverage (DOL) = % Change in Operating Income / % Change in Revenue
- High DOL (>3x) amplifies both upside and downside from revenue swings
| Year | Revenue ($M) | Revenue Growth % | EBIT ($M) | EBIT Growth % | DOL |
|---|---|---|---|---|---|
| Y-4 | |||||
| Y-3 | |||||
| Y-2 | |||||
| Y-1 | |||||
| TTM |
Working Capital Cycle Analysis
Working capital efficiency directly affects how much cash a business consumes or generates as it grows.
Key Working Capital Metrics
| Metric | Formula | Current | Y-1 | Y-2 | Trend |
|---|---|---|---|---|---|
| Days Sales Outstanding (DSO) | Accounts Receivable / (Revenue / 365) | ||||
| Days Inventory Outstanding (DIO) | Inventory / (COGS / 365) | ||||
| Days Payable Outstanding (DPO) | Accounts Payable / (COGS / 365) | ||||
| Cash Conversion Cycle (CCC) | DSO + DIO − DPO | ||||
| Net Working Capital ($M) | Current Assets − Current Liabilities | ||||
| NWC as % of Revenue | NWC / Revenue |
Cash Conversion Cycle Interpretation
- CCC declining: Company is collecting faster, holding less inventory, and/or extending payables — favorable working capital dynamics, cash generation improves as revenue grows
- CCC rising: Working capital is consuming more cash as the business scales — a hidden drag on FCF growth
- Negative CCC (e.g., large retailers, subscription businesses): Customers pay before the company pays suppliers — a structural cash flow advantage
Working Capital as a Growth Funding Check
- Incremental NWC per $1 of new revenue = ΔNWC / ΔRevenue
- If this ratio exceeds ~15%, rapid revenue growth can strain liquidity even in a profitable business
DuPont Decomposition
DuPont analysis decomposes ROE into its constituent drivers to identify whether profitability, efficiency, or leverage is the primary return engine — and whether returns are sustainable.
3-Factor DuPont
ROE = Net Profit Margin × Asset Turnover × Equity Multiplier
| Component | Formula | Current | Y-1 | Y-2 |
|---|---|---|---|---|
| Net Profit Margin | Net Income / Revenue | |||
| Asset Turnover | Revenue / Average Total Assets | |||
| Equity Multiplier | Average Total Assets / Average Shareholders' Equity | |||
| ROE | Margin × Turnover × Multiplier |
5-Factor DuPont (Extended)
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier
| Component | Formula | Current | Y-1 | Y-2 |
|---|---|---|---|---|
| Tax Burden | Net Income / Pre-Tax Income | |||
| Interest Burden | Pre-Tax Income / EBIT | |||
| EBIT Margin | EBIT / Revenue | |||
| Asset Turnover | Revenue / Average Total Assets | |||
| Equity Multiplier | Average Total Assets / Average Equity | |||
| ROE | Product of all five |
DuPont Interpretation
- ROE driven by high margin (e.g., luxury brands, software): High-quality, sustainable — least risky driver
- ROE driven by high asset turnover (e.g., retailers, distributors): Efficient but thin — watch for margin erosion
- ROE driven by high leverage (equity multiplier > 3x): Amplified returns but magnified downside — assess debt sustainability carefully
- Declining ROE: diagnose which factor is deteriorating before drawing conclusions
Competitive Analysis — Porter's Five Forces
| Force | Intensity (H/M/L) | Key Evidence |
|---|---|---|
| Threat of New Entrants | Capital requirements, brand moats, regulatory barriers | |
| Bargaining Power of Suppliers | Supplier concentration, switching costs, input criticality | |
| Bargaining Power of Buyers | Customer concentration, price sensitivity, alternatives | |
| Threat of Substitutes | Technology disruption, cross-industry competition | |
| Competitive Rivalry | Number of peers, market growth rate, differentiation |
Overall Moat Assessment: Wide / Narrow / None
- Wide moat: Durable competitive advantage expected to persist 20+ years
- Narrow moat: Competitive advantage present but may erode within 10 years
- No moat: Competing primarily on price or operational efficiency
Visualization Data Tables
When a visual or report output is needed, populate these tables for chart generation (compatible with /us-stock-analysis:report-generator):
Revenue & Earnings Growth
Year Revenue ($M) Revenue Growth % Net Income ($M) EPS ($)
2020 [value] [%] [value] [value]
2021 [value] [%] [value] [value]
2022 [value] [%] [value] [value]
2023 [value] [%] [value] [value]
2024 [value] [%] [value] [value]
Profit Margin Trends
Year Gross Margin % Operating Margin % Net Margin % Industry Avg %
2020 [%] [%] [%] [%]
2021 [%] [%] [%] [%]
2022 [%] [%] [%] [%]
2023 [%] [%] [%] [%]
2024 [%] [%] [%] [%]
Balance Sheet Composition
Year Current Assets ($M) Fixed Assets ($M) Intangibles ($M) Total Assets ($M)
2020 [value] [value] [value] [value]
2021 [value] [value] [value] [value]
2022 [value] [value] [value] [value]
2023 [value] [value] [value] [value]
2024 [value] [value] [value] [value]
Year Current Liab ($M) Long-term Debt ($M) Equity ($M) Total L+E ($M)
2020 [value] [value] [value] [value]
2021 [value] [value] [value] [value]
2022 [value] [value] [value] [value]
2023 [value] [value] [value] [value]
2024 [value] [value] [value] [value]
Cash Flow Waterfall
Component Amount ($M) Notes
Operating Cash Flow [value] Core business generation
Capital Expenditures [value] Investments in assets
Free Cash Flow [value] Available for distribution
Dividends [value] Shareholder distribution
Share Buybacks [value] Share repurchases
M&A Activity [value] Acquisitions
Debt Repayment [value] Debt reduction
Net Cash Change [value] Bottom line impact
Valuation Multiples Comparison
Metric Company Industry Avg 5-Year Avg Assessment
P/E Ratio [value] [value] [value] [Over/Under/Fair]
P/B Ratio [value] [value] [value] [Over/Under/Fair]
P/S Ratio [value] [value] [value] [Over/Under/Fair]
EV/EBITDA [value] [value] [value] [Over/Under/Fair]
PEG Ratio [value] [value] [value] [Over/Under/Fair]
Quality Scoring Framework
Piotroski F-Score (0–9)
The Piotroski F-Score measures financial strength and operating improvement across 9 binary criteria. Each criterion scores 1 (pass) or 0 (fail). Score of 8–9 is strong; 0–2 is weak.
Profitability Signals (4 criteria):
| # | Criterion | Formula | Pass Condition | Score |
|---|---|---|---|---|
| 1 | ROA > 0 | Net Income / Total Assets | Positive ROA in current year | 0 or 1 |
| 2 | Operating Cash Flow > 0 | CFO from cash flow statement | Positive CFO | 0 or 1 |
| 3 | Change in ROA | ROA(t) − ROA(t-1) | ROA improved year-over-year | 0 or 1 |
| 4 | Accruals (quality) | CFO / Total Assets > ROA | Cash earnings exceed reported earnings | 0 or 1 |
Leverage, Liquidity & Source of Funds (3 criteria):
| # | Criterion | Formula | Pass Condition | Score |
|---|---|---|---|---|
| 5 | Change in Leverage | Long-term Debt / Avg Assets | Leverage decreased YoY | 0 or 1 |
| 6 | Change in Liquidity | Current Ratio(t) vs (t-1) | Current ratio improved YoY | 0 or 1 |
| 7 | No New Shares Issued | Diluted shares outstanding | No new equity issuance in past year | 0 or 1 |
Operating Efficiency (2 criteria):
| # | Criterion | Formula | Pass Condition | Score |
|---|---|---|---|---|
| 8 | Change in Gross Margin | Gross Margin(t) vs (t-1) | Gross margin expanded YoY | 0 or 1 |
| 9 | Change in Asset Turnover | Revenue / Total Assets | Asset turnover improved YoY | 0 or 1 |
F-Score Interpretation:
- 8–9: Strong financial position — high-quality candidate
- 5–7: Average quality — neutral
- 0–2: Weak financial position — high risk of deterioration
Earnings Quality Score
- Accruals Ratio: (Net Income − CFO) / Average Total Assets. Low or negative accruals indicate high earnings quality (cash-backed profits).
- Cash Conversion Rate: CFO / Net Income. Ratio consistently above 1.0x is positive. Below 0.7x signals potential earnings inflation.
- Non-Recurring Items: Identify and strip out restructuring charges, asset write-downs, gains on asset sales, and one-time tax benefits from normalized earnings.
- Revenue Recognition Risk: Assess channel stuffing, bill-and-hold arrangements, and aggressive deferred revenue recognition.
ROIC / WACC Analysis
ROIC Calculation
ROIC = NOPAT / Invested Capital
- NOPAT (Net Operating Profit After Tax) = EBIT × (1 − effective tax rate)
- Invested Capital = Total Equity + Total Debt − Cash and Cash Equivalents
- Alternatively: Invested Capital = Net PP&E + Net Working Capital + Goodwill + Other Long-term Operating Assets
| Component | Value |
|---|---|
| EBIT | |
| Effective Tax Rate | |
| NOPAT | |
| Total Equity | |
| Total Debt | |
| Less: Cash | |
| Invested Capital | |
| ROIC |
WACC Calculation
WACC = (E/V) × Re + (D/V) × Rd × (1 − T)
- Cost of Equity (Re) via CAPM: Re = Rf + β × (Rm − Rf)
- Rf: Risk-free rate (current 10-year Treasury yield)
- β: Stock beta (5-year monthly vs. S&P 500)
- (Rm − Rf): Equity risk premium (historical ~5–6%)
- Cost of Debt (Rd): Weighted average interest rate on outstanding debt
- Capital Structure Weights: E/V = market cap / (market cap + total debt), D/V = total debt / (market cap + total debt)
- Tax Shield: Multiply Rd by (1 − marginal tax rate) to reflect interest deductibility
| Component | Value |
|---|---|
| Risk-Free Rate (Rf) | |
| Beta (β) | |
| Equity Risk Premium | |
| Cost of Equity (Re) | |
| Pre-Tax Cost of Debt | |
| Tax Rate | |
| After-Tax Cost of Debt | |
| Equity Weight (E/V) | |
| Debt Weight (D/V) | |
| WACC |
Economic Value Added (EVA)
EVA = (ROIC − WACC) × Invested Capital
- ROIC > WACC: Company is creating economic value — every dollar invested earns more than its cost. Strong positive signal.
- ROIC = WACC: Company is breaking even economically — no value creation or destruction.
- ROIC < WACC: Company is destroying shareholder value — capital is deployed below its opportunity cost. Significant warning sign.
ROIC vs. WACC spread trend (expanding = improving value creation, compressing = deteriorating):
| Year | ROIC | WACC | Spread | EVA |
|---|---|---|---|---|
| Current | ||||
| -1 Year | ||||
| -2 Year | ||||
| -3 Year |
DCF Framework
Step-by-Step DCF Methodology
Step 1 — Project Free Cash Flow (Years 1–10)
- Start with current year base FCF = Operating Cash Flow − Maintenance Capex
- Apply revenue growth rate assumptions (differentiate Phase 1: high growth, Phase 2: fade to stable)
- Apply operating margin assumptions (expanding/stable/compressing)
- Deduct taxes and changes in net working capital
- FCF = NOPAT + D&A − Change in Working Capital − Capex
Step 2 — Terminal Value Calculation
- Gordon Growth Model: TV = FCF(Year 10) × (1 + g) / (WACC − g)
- Exit Multiple Method: TV = EBITDA(Year 10) × Terminal EV/EBITDA multiple
- Terminal growth rate (g): typically 2–3% (in line with long-run nominal GDP growth)
- Cross-check both methods for reasonableness
Step 3 — Discount to Present Value
- Discount each year's FCF: PV(FCFt) = FCFt / (1 + WACC)^t
- Discount terminal value: PV(TV) = TV / (1 + WACC)^10
- Enterprise Value = Sum of all discounted FCFs + PV(Terminal Value)
- Equity Value = Enterprise Value − Net Debt
- Intrinsic Value Per Share = Equity Value / Diluted Shares Outstanding
Key Assumptions
| Assumption | Base Case | Bull Case | Bear Case |
|---|---|---|---|
| Revenue Growth Yr 1–5 | |||
| Revenue Growth Yr 6–10 | |||
| Operating Margin | |||
| Tax Rate | |||
| Capex (% Revenue) | |||
| WACC | |||
| Terminal Growth Rate | |||
| Terminal EV/EBITDA |
Sensitivity Table
Intrinsic value per share at various WACC and terminal growth rate combinations:
| WACC \ Terminal Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7% | |||||
| 8% | |||||
| 9% | |||||
| 10% | |||||
| 11% |
Margin of Safety Assessment
- Intrinsic Value (Base Case):
- Current Market Price:
- Premium / (Discount) to Intrinsic Value:
- Margin of Safety: (Intrinsic Value − Market Price) / Intrinsic Value × 100%
30% discount: Significant margin of safety — compelling value
- 10–30% discount: Moderate margin of safety — attractive
- 0–10% discount: Limited margin of safety — fairly valued
- Trading at premium: No margin of safety — risk of capital loss if assumptions miss
Management Quality Assessment
Capital Allocation Track Record
- ROIC Trend: Is management generating returns above cost of capital consistently? Review 5-year ROIC history.
- Acquisition History: Evaluate past M&A for value creation. Did acquired assets earn above WACC? Were goodwill impairments taken post-acquisition?
- Buyback Timing: Did management repurchase shares below intrinsic value? Assess buyback price vs. subsequent performance.
- Dividend Policy: Sustainable payout ratio? Dividend growth track record. Balance between dividends, buybacks, and reinvestment.
- Capex Discipline: Differentiate growth capex vs. maintenance capex. Asset-light vs. capital-intensive business assessment.
Guidance Accuracy History (Last 8 Quarters)
| Quarter | EPS Guidance | EPS Actual | Beat/Miss | Revenue Guidance | Revenue Actual | Beat/Miss |
|---|---|---|---|---|---|---|
| Q1 | ||||||
| Q2 | ||||||
| Q3 | ||||||
| Q4 | ||||||
| Q5 | ||||||
| Q6 | ||||||
| Q7 | ||||||
| Q8 | ||||||
| Rate | X/8 | X/8 |
- Beat rate above 75% (6+/8) is strong. Below 50% suggests overpromising or deteriorating visibility.
- Assess guidance conservatism (sandbagging tendency) vs. optimism bias.
Insider Ownership Alignment
- CEO ownership (% of shares outstanding): > 3% meaningful, > 10% highly aligned
- Board ownership: Independent directors with meaningful personal stakes indicate alignment
- Recent insider transactions: Open-market buys are strongly positive; sells can be routine diversification
- Insider buy/sell ratio over past 12 months
- 10b5-1 plan activity: Scheduled plan sales are less informative than discretionary transactions
Compensation Structure
- Pay-for-performance alignment: Are bonuses and equity vesting tied to ROIC, FCF, and total shareholder return (TSR)?
- Long-term equity grants: Stock option or RSU vesting periods (3+ years preferred)
- CEO pay ratio: Context for compensation relative to company size and peers
- Say-on-pay vote: Shareholder approval percentage in most recent proxy vote
- Excessive compensation red flags: Guaranteed bonuses, repriced options, change-of-control severance packages
Analyst Consensus Tracking
Current Consensus Summary
| Metric | Value |
|---|---|
| Buy Ratings | X (X%) |
| Hold Ratings | X (X%) |
| Sell Ratings | X (X%) |
| Mean Price Target | |
| High Price Target | |
| Low Price Target | |
| Current Price | |
| Upside to Mean Target | |
| # of Analysts |
Consensus interpretation:
70% Buy with >20% upside to mean target: Strong consensus support
- Mixed ratings with tight price target range: Consensus uncertainty
30% Sell ratings or mean target below current price: Consensus cautious
Estimate Revision Trend
Track the direction of earnings estimate changes over time:
| Period | EPS Estimate (Current FY) | Change vs. 30 Days Ago | Change vs. 90 Days Ago |
|---|---|---|---|
| Current FY | |||
| Next FY | |||
| Revenue (FY) |
- Estimates rising: Positive revision momentum — analysts upgrading expectations
- Estimates falling: Negative revision momentum — earnings risk, watch for guidance cuts
- Stable estimates: Predictable business with low estimate volatility
Earnings Estimate Revision Momentum (ERM Signal)
- ERM = (Number of upward revisions − Number of downward revisions) / Total revisions over 30 days
- ERM > +0.3: Strong positive momentum — bullish signal
- ERM −0.3 to +0.3: Neutral
- ERM < −0.3: Negative momentum — bearish signal
- Most reliable when combined with price momentum confirmation
Risk Assessment Matrix
Business Risk
| Risk Factor | Level (L/M/H) | Notes |
|---|---|---|
| Industry cyclicality | ||
| Competitive intensity | ||
| Disruption threat | ||
| Customer concentration | ||
| Supplier concentration | ||
| Regulatory exposure | ||
| ESG / litigation |
Financial Risk
| Risk Factor | Level (L/M/H) | Notes |
|---|---|---|
| Leverage (Net Debt/EBITDA) | ||
| Liquidity (Current Ratio) | ||
| Refinancing risk (near-term maturities) | ||
| Covenant compliance | ||
| Pension obligations | ||
| Off-balance-sheet items |
Leverage thresholds (Net Debt/EBITDA):
- < 1.0x: Conservative, strong balance sheet
- 1.0–2.5x: Moderate, manageable
- 2.5–4.0x: Elevated, monitor closely
4.0x: High financial risk, limited flexibility
Valuation Risk
| Scenario | Implied Multiple | Notes |
|---|---|---|
| Bull case intrinsic value | ||
| Base case intrinsic value | ||
| Bear case intrinsic value | ||
| Current market price | ||
| Premium to bear case |
- Multiple compression scenario: If sector re-rates to lower multiples (e.g., in rising rate environment), what is the downside?
- Earnings miss scenario: What happens to price if EPS misses by 10%? By 20%?
- Sentiment shift risk: High-multiple, high-expectation stocks carry disproportionate downside on minor guidance cuts.
Macro Risk
| Factor | Impact Level | Current Exposure |
|---|---|---|
| Interest rate sensitivity | ||
| USD/FX exposure | ||
| Commodity cost exposure | ||
| Tariff / trade risk | ||
| Geopolitical exposure | ||
| Regulatory / antitrust |
Output Format
Provide clear, actionable insights structured as follows:
- Investment Thesis Summary (2–3 sentences capturing the core bull or bear case)
- Valuation Assessment: Undervalued / Fairly Valued / Overvalued, with DCF and multiple-based support
- Quality Score: Piotroski F-Score, Earnings Quality, ROIC vs. WACC verdict
- Management Assessment: Capital allocator quality, guidance credibility, ownership alignment
- Analyst Consensus: Current ratings, price target vs. market, estimate revision direction
- Key Risks: Top 3 risks that could invalidate the thesis
- Price Targets: Bull / Base / Bear case with probability weighting
- Recommended Entry Zone: Based on margin of safety and technical support levels
Standard Signal Output
All analysis concludes with this standardized block:
## Thesis Invalidation
After delivering the analysis signal, specify what would reverse it:
**If signal is BULLISH — thesis breaks if:**
- Price closes below the MA200 / key support level identified in this analysis on above-average volume
- Piotroski F-Score drops below 3 OR ROIC falls below WACC for 2 quarters
- Macro regime shift: Fed pivots hawkish unexpectedly, recession probability >60%
**If signal is BEARISH — thesis breaks if:**
- Price closes above key resistance / MA200 level with volume confirmation
- F-Score improves to 7+ AND ROIC/WACC spread widens >300bps
- Fundamental improvement: surprise earnings beat >20% with guidance raise
**Re-run this analysis when:**
- [ ] Next earnings release
- [ ] Price moves ±15% from current level
- [ ] 60 days have elapsed
- [ ] Material news event (acquisition, leadership change, regulatory decision)
╔══════════════════════════════════════════════╗
║ INVESTMENT SIGNAL ║
╠══════════════════════════════════════════════╣
║ Signal: BULLISH / NEUTRAL / BEARISH ║
║ Confidence: HIGH / MEDIUM / LOW ║
║ Horizon: SHORT / MEDIUM / LONG-TERM ║
║ Score: X.X / 10 ║
╠══════════════════════════════════════════════╣
║ Action: BUY / HOLD / SELL ║
║ Conviction: STRONG / MODERATE / WEAK ║
╚══════════════════════════════════════════════╝
Score Guide: 8.0–10.0 Strongly Bullish | 6.0–7.9 Moderately Bullish | 4.0–5.9 Neutral | 2.0–3.9 Moderately Bearish | 0.0–1.9 Strongly Bearish Confidence: HIGH (strong data, clear signals) | MEDIUM (mixed signals) | LOW (limited data, conflicting signals) Horizon: SHORT-TERM (1 week–3 months) | MEDIUM-TERM (3 months–1 year) | LONG-TERM (1+ years)